About Us

AbGenomics Holding Ltd is established to serve as a platform to facilitate global positioning and resources integration to help all members of AbGenomics group to strive worldwide. On January 3, 2017, AbGenomics International completed a share swap with AbGenomics Holding Ltd (Cayman) and become a fully owned subsidiary of AbGenomics Holding Ltd. Through AbGenomics International Inc., a clinical-stage biopharmaceutical company located in the San Francisco Bay Area and AbGenomics Research and Administration Center located in Neihu Technology Park, Taipei, Taiwan, AbGenomics group is focusing on developing novel best-in-class therapeutics for inflammatory/autoimmune diseases and cancers.Learn more

Pipeline Highlights

View full chart